Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
The microenvironment of a tumor may regulate the anti-tumor immune response. Intratumoral acidosis and hypoxia may suppress lymphocyte proliferation and migration, and this may have important implications in modern immunotherapy. The expression of PD-L1 by cancer cells and of PD-1 by tumor infiltrat...
Main Authors: | Giatromanolaki, A, Koukourakis, IM, Balaska, K, Mitrakas, AG, Harris, AL, Koukourakis, MI |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Springer
2019
|
Registos relacionados
-
FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma
Por: Giatromanolaki, A, et al.
Publicado em: (2019) -
Role of PD-1/PD-L1 in acute and chronic graft versus host disease
Por: Blazar, B, et al.
Publicado em: (2015) -
Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer
Por: Islam, Mohammad Kaisarul, et al.
Publicado em: (2021) -
Function of PD-L1 in antitumor immunity of glioma cells
Por: Lou, Y.L., et al.
Publicado em: (2017) -
PD-L1 alternative splicing
Por: Zhen, Yashu
Publicado em: (2022)